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Abstract
Background: Bronchus-associated lymphoid tissue (BALT) is the secondary lymphoid tissue in
bronchial mucosa and is involved in the development of bronchopulmonary immune responses.
Although migration of lymphocytes from blood vessels into secondary lymphoid tissues is critical
for the development of appropriate adaptive immunity, the endothelia and lymphocyte adhesion
molecules that recruit specific subsets of lymphocytes into human BALT are not known. The aim
of this study was to determine which adhesion molecules are expressed on lymphocytes and high
endothelial venules (HEVs) in human BALT.
Methods: We immunostained frozen sections of BALT from lobectomy specimens from 17
patients with lung carcinoma with a panel of monoclonal antibodies to endothelia and lymphocyte
adhesion molecules.
Results: Sections of BALT showed B cell follicles surrounded by T cells. Most BALT CD4+ T cells
had a CD45RO+ memory phenotype. Almost all BALT B cells expressed α4 integrin and L-selectin.
In contrast, 43% of BALT T cells expressed α4 integrin and 20% of BALT T cells expressed L-
selectin. Almost all BALT lymphocytes expressed LFA-1. HEVs, which support the migration of
lymphocytes from the bloodstream into secondary lymphoid tissues, were prominent in BALT. All
HEVs expressed peripheral node addressin, most HEVs expressed vascular cell adhesion molecule-
1, and no HEVs expressed mucosal addressin cell adhesion molecule-1.
Conclusion: Human BALT expresses endothelia and lymphocyte adhesion molecules that may be
important in recruiting naive and memory/effector lymphocytes to BALT during protective and
pathologic bronchopulmonary immune responses.
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Background
The lower respiratory tract is continually exposed to a
wide variety of airborne antigens and microorganisms.
The generation of rapid, specific adaptive immune
responses to inhaled antigens and pathogens is critical for
survival. Unfortunately, in some inflammatory and infec-
tious diseases, such as asthma and tuberculosis, these
immune responses can damage the lungs and bronchi.
Thus, the bronchopulmonary adaptive immune system is
involved in the maintenance of health and the develop-
ment of diseases of the lower respiratory tract.
In the initiation stage of an adaptive immune response,
naive T cells migrate through blood vessel high endothelia
venules (HEVs) into secondary lymphoid tissues, where
they are stimulated by antigen-bearing dendritic cells.
This leads to the generation of antigen-specific effector
and memory T cells and B cells, which are released from
the secondary lymphoid tissue into the bloodstream. In
the effector stage of the adaptive immune response, some
of the memory T cells and B cells migrate from blood ves-
sels into nonlymphoid tissue(s) that contain the cognate
antigens or pathogens [1-4]. The lower respiratory tract
has two distinct types of secondary lymphoid tissues:
bronchus-associated lymphoid tissue (BALT) and lymph
nodes (LNs) [5-7]. The presence of BALT in adult mam-
mals depends on species, antigen stimulation and age [6-
8]. BALT is found in normal lungs of most healthy adult
rabbits, rats, guinea pigs and old adult mice [5,6,9-13]. In
contrast, the presence and frequency of BALT in normal
lungs of healthy adult humans is controversial [5,14-20].
BALT is the site of initial presentation of inhaled antigens,
which are transported from the bronchial lumen by spe-
cialized cells (likely M cells and/or dendritic cells) in the
epithelia over the BALT, to naive T cells, which enter the
BALT through blood vessel HEVs [21-26]. Intravascular
lymphocytes must bind to the endothelial surface of HEVs
in BALT and other secondary lymphoid tissues, prior to
migrating through the vessel wall into the tissue [1,9,27].
Thus, the adhesion molecules expressed on the surface of
the HEVs help determine which subsets of lymphocytes
can migrate into the tissue. There are three distinct, tissue-
selective combinations of adhesion molecules on HEVs in
secondary lymphoid tissues. Most HEVs in peripheral LNs
of mice and humans express peripheral node addressin
(PNAd), but not mucosal addressin cell adhesion mole-
cule-1 (MAdCAM-1) and vascular cell adhesion molecule-
1 (VCAM-1). Most HEVs in small intestine Peyer's patches
(PP) express MAdCAM-1, but not VCAM-1 and luminal
PNAd. Most HEVs in mouse BALT express PNAd and
VCAM-1, but not MAdCAM-1 [1,9,27]. In vivo studies
from our laboratory indicate that migration of B cells and
naive T cells into mouse BALT largely depends on
endothelial PNAd and its lymphocyte ligand L-selectin,
while migration of memory T cells into BALT requires
endothelial VCAM-1 and lymphocyte α4  integrin [9].
However, the adhesion molecules that are highly
expressed on HEVs in human BALT are not known.
In this study, we evaluated BALT tissue from lobectomy
specimens of 17 human adults with lung carcinoma. We
found that BALT HEVs expressed PNAd and VCAM-1 but
not MAdCAM-1. Most BALT B cells and some T cells
expressed L-selectin and α4 integrin. Most BALT CD4+ T
cells had a memory phenotype. These results suggest that
human BALT expresses endothelia and lymphocyte adhe-
sion molecules that may be important in recruiting naive
and memory/effector lymphocytes to BALT, where they
may be involved in the initiation of bronchopulmonary
immune responses to inhaled antigens and pathogens.
Methods
Tissue collection, frozen sectioning and histologic 
identification of BALT
Bronchus tissue was obtained from 49 patients who
underwent lobectomy for lung carcinoma at Kagoshima
Kouseiren Hospital, Kagoshima, Japan. Patients with pul-
monary inflammatory disorders, such as asthma, chronic
obstructive pulmonary disease, rheumatoid lung, and
post-obstructive pneumonia due to tumor, were excluded
from the study. Tissue samples, each ≥2 cm in maximum
dimension, of bronchus and surrounding lung were taken
from at least 2 nonadjacent sites in each lobectomy speci-
men. The sampling was carefully performed to exclude
tumor. Each tissue sample was infused with a 1:1 mixture
of OCT compound (Sakura Finetek, Tokyo, Japan) and
phosphate-buffered saline (PBS), and frozen in OCT com-
pound. A frozen section was cut, fixed in methanol,
stained with hematoxylin and examined by light micros-
copy for "classic" BALT, as defined using the histologic cri-
teria originally described and illustrated by Bienenstock
and colleagues [5]. These criteria are listed in the first par-
agraph of the Results section. If "classic" BALT was identi-
fied on the hematoxylin-stained section, additional
sections were cut, fixed in acetone, and stored at -20°C for
immunostaining. If there was no BALT on the hematoxy-
lin-stained section, we continued to cut and examine sec-
tions at 100 μm intervals until BALT was found, or the
block was cut through.
Small intestine PPs, obtained from ileocecal resection
specimens from 3 patients with colon carcinoma, were
frozen in OCT compound. Frozen sections were cut, fixed
in acetone, and stored at -20°C for immunostaining.
Antibodies and other reagents
Mouse and rat monoclonal antibodies (mAbs) used in
this study are listed in Table 1. Biotin-anti-mouse IgG pol-
yclonal antibody was purchased from eBioscience (SanRespiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
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Diego, CA). Biotin-anti-rat IgM polyclonal antibody and
peroxidase-streptavidin were obtained from Jackson
ImmunoResearch Laboratories (West Grove, PA). AEC
substrate kit and Alexa Fluor 546-streptavidin were from
Vector Laboratories (Burlingame, CA) and Molecular
Probes (Eugene, OR), respectively.
Immunohistochemical staining
Acetone-fixed frozen sections of BALT and PP were incu-
bated with mAb against CD31, MAdCAM-1, VCAM-1 or
PNAd, or with a species- and isotype-matched negative
control mAb, at room temperature for 1 hour (hr). Sec-
tions were rinsed in PBS, incubated with biotin-anti-
mouse IgG (to detect CD31, MAdCAM-1 or VCAM-1) or
biotin-anti-rat IgM (to detect PNAd) at room temperature
for 30 minutes (min), rinsed in PBS, and incubated with
peroxidase-streptavidin for 30 min. After a final PBS wash,
slides were incubated with Vector AEC substrate (per
manufacturer's instructions), stained with hematoxylin,
and cover-slipped. Sections were evaluated by light micro-
scopy.
Immunofluorescence (IF) staining
To evaluate expression of ICAM-1 and ICAM-2 on blood
vessel endothelia, frozen sections of BALT and PP were
sequentially incubated with anti-ICAM-1 mAb, anti-
ICAM-2 mAb or negative control mAb (1 hr), biotin-anti-
mouse IgG (30 min), and Alexa Fluor 546-streptavidin
(30 min).
To identify B cells and T cells, frozen sections of BALT and
PP were sequentially incubated with anti-CD19 mAb (1
hr), biotin-anti-mouse IgG (30 min), 10% normal mouse
serum (30 min), and Alexa Fluor 546-streptavidin com-
bined with FITC-anti-CD3 mAb (30 min). CD4+ cells and
CD8+ cells were identified by incubating the sections with
PE-anti-CD4 and FITC-anti-CD8 mAbs (30 min). Naive
CD4+ cells were identified by staining with PE-anti-CD4
and FITC-anti-CD45RA mAbs, while memory CD4+ cells
were identified by staining with PE-anti-CD4 and FITC-
anti-CD45RO mAbs. We counted CD4+CD45RA+  cells
(naive CD4+ T cells) and CD4+CD45RO+ cells (memory
CD4+ T cells) in BALT from 7 randomly selected patients,
and calculated the percent of CD4+ T cells with naive or
memory phenotype.
To evaluate co-expression of VCAM-1 and PNAd on BALT
HEVs, sections were sequentially incubated with anti-
VCAM-1 mAb (1 hr), biotin-anti-mouse IgG in 4% nor-
mal human serum (30 min), 10% normal rat serum (30
min), and FITC-anti-PNAd mAb combined with Alexa
Fluor 546-streptavidin (30 min). In 5 randomly selected
patients, we determined the percentage of PNAd+ HEVs
that expressed VCAM-1.
To evaluate expression of adhesion molecules on BALT
lymphocytes, sections were incubated with FITC-anti-
CD3 mAb combined with PE-anti-LFA-1, PE-anti-α4
integrin, or PE-anti-L-selectin mAb (30 min). We counted
Table 1: Monoclonal Antibodies Used for Tissue Immunostaining
mAb Clone Species Isotype Source
CD3 UCHT1 mouse IgG1 BD Biosciences
CD4 RPA-T4 mouse IgG1 eBioscience
CD8 RPA-T8 mouse IgG1 eBioscience
CD19 HIB19 mouse IgG1 BD Biosciences
CD45RA HI100 mouse IgG2b BD Biosciences
CD45RO UCHL1 mouse IgG2a eBioscience
CD11a/LFA-1 HI111 mouse IgG1 eBioscience
CD49d/α4 integrin 9F10 mouse IgG1 eBioscience
CD62L/L-selectin Dreg 56 mouse IgG1 BD Biosciences
CD31/PECAM-1 WM59 mouse IgG1 eBioscience
CD54/ICAM-1 HA58 mouse IgG1 eBioscience
CD102/ICAM-2 CBR/IC2/2 mouse IgG2a Caltag Laboratories
MAdCAM-1 MMC3 mouse IgG1 Dina Washington, Genentech
PNAd MECA79 rat IgM Dr. Eugene C. Butcher, Stanford University
CD106/VCAM-1 D8 mouse IgG1 Dr. Takami Matsuyama, Kagoshima University
Species and isotype matched negative controls N/A mouse IgG1 eBioscience
N/A mouse IgG2a eBioscience
N/A mouse IgG2b eBioscience
OZ42 rat IgM Dr. Leslie PickfordRespiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
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total T cells (CD3+) and T cells expressing LFA-1, α4
integrin or L-selectin in BALT from 6 randomly selected
patients, and calculated the percentage of T cells that
expressed each adhesion molecule. In a similar manner,
we determined the proportion of B cells (CD3-  lym-
phocytes in the B cell follicle) that expressed each adhe-
sion molecule.
For each tissue, primary mAbs were replaced by conjuga-
tion-, species- and isotype-matched negative control
mAbs. All slides were viewed and imaged using a confocal
microscope.
Ethics
The ethics committee of the Graduate School of Medical
and Dental Sciences, Kagoshima University, Japan
approved this study. Each patient gave written informed
consent to use tissue for research.
Statistical analysis
All data are expressed as mean ± standard derivation (SD).
Chi-square test was used to evaluate the difference in the
frequency of BALT between groups. P < 0.05 was consid-
ered to be statistically significant.
Results
Detection of BALT in adult human lung
We examined hematoxylin-stained frozen sections of
bronchi from lung carcinoma lobectomy specimens for
BALT. We used histologic criteria that were originally pro-
posed by Bienenstock and are extensively described in the
human histopathology literature [5,28,29]. Specifically,
BALT: 1) consists of lymphoid follicle(s) in the bronchial
mucosa; 2) is fairly well circumscribed, without inflam-
mation or damage of the adjacent bronchus tissue, 3) has
prominent HEVs, and no or small germinal centers; 4)
may contain pigment-filled macrophages, but no neu-
trophils or eosinophils; and 5) lacks evidence of signifi-
cant epithelial injury. If BALT was identified on the
hematoxylin-stained section (Fig. 1A), we immediately
cut additional sections from the frozen tissue block for
immunohistology staining. In some specimens, we found
a few small, poorly demarcated lymphoid aggregates in
the pulmonary parenchyma (Fig. 1B). These aggregates,
which were not associated with a bronchus, were not ana-
lyzed in this study.
We identified BALT on hematoxylin-stained frozen sec-
tions of bronchus from 17/49 (35%) lung lobectomy
specimens (Fig. 1A). BALT was identified in 40% of the
lobectomy specimens from men and 26% of the speci-
mens from women. Current smokers (42%) were more
likely to have BALT than were previous smokers (25%) or
non-smokers (29%). BALT was slightly more common in
patients over the age of 70 years (37%) than in those 70
years or younger (32%). BALT was found in 43% of
patients with squamous cell carcinoma and 31% of
patients with adenocarcinomas. None of these differences
were statistically significant (p > 0.05 for all factors, Chi-
square test).
Adhesion molecules on BALT HEVs
To determine which adhesion molecules are expressed on
BALT HEVs, we stained frozen sections of BALT with
mAbs against endothelia adhesion molecules that are
expressed by HEVs in secondary lymphoid tissues. These
adhesion molecules include PNAd, which is highly
expressed by HEVs in peripheral LNs and mouse BALT;
Lymphoid tissue in human lung Figure 1
Lymphoid tissue in human lung. (A): Bronchus-associ-
ated lymphoid tissue (BALT). There is a well demarcated 
submucosal lymphoid follicle in the wall of a bronchus. The 
arrow is in the bronchial lumen, pointing to the bronchial 
epithelia. (B): Nonspecific lymphoid aggregate. There is a 
small, poorly demarcated lymphoid aggregate in a small focus 
(<1 mm diameter) of scar tissue in the lung interstitium. The 
aggregate is not associated with a bronchus. This aggregate 
does not meet the histologic criteria for BALT and is not 
included in this study. (hematoxylin and eosin stained frozen 
sections; original magnification 200×).Respiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
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MAdCAM-1, which is expressed by HEVs in small intes-
tine PPs; VCAM-1, which is highly expressed by HEV
endothelia in mouse BALT; and ICAM-1 and ICAM-2,
which are expressed by HEVs in LNs, PPs and mouse BALT
[1,9]. For comparison to BALT, we also stained sections of
PP.
There was strong expression of PNAd on all HEVs in BALT
(Fig. 2A) and on a few small vessels in PP (Fig. 2B).
VCAM-1 was expressed on many HEVs in BALT, on rare
HEVs in PP, and on many non-endothelial cells in BALT
and PP (Figs. 2C, D). There was no staining for MAdCAM-
1 on BALT HEVs in any of the patients (Fig. 2E). Bronchial
venules that were not in BALT did not express PNAd,
VCAM-1 or MAdCAM-1 (not shown), indicating that the
bronchi were not chronically inflamed. As expected, there
was strong staining for MAdCAM-1 on PP HEVs (Fig. 2F)
[30]. ICAM-1 and ICAM-2 were strongly expressed on
HEVs in BALT and PP (data not shown). Negative control
mAbs did not stain vascular endothelia in BALT or PP sec-
tions (Figs. 2G, H).
VCAM-1 is known to be expressed by a variety of non-
endothelial cells, including follicular dendritic cells and
blood vessel pericytes, in human secondary lymphoid tis-
sues [31]. Because of this extensive expression, it is diffi-
cult to determine which cells are stained with an anti-
VCAM-1 mAb on single color immunohistology slides
(Figs. 2C, D). To focus on VCAM-1 expression by HEV
endothelia, we stained frozen sections of BALT for PNAd
and VCAM-1 by two-color IF (Figs. 2I-N). Quantitative
evaluation revealed that 66 ± 11% of BALT HEVs, as iden-
tified by high endothelial morphology and expression of
PNAd, were PNAd+  VCAM-1+  and 33 ± 11% were
PNAd+VCAM-1- (n = 5 patients).
These results indicate that the HEV adhesion molecules
that are available to recruit lymphocytes into BALT differ
significantly from those that are available to recruit lym-
phocytes into PP. Specifically, in BALT, all HEVs expressed
PNAd, most HEVs expressed VCAM-1, and no HEVs
expressed MAdCAM-1. In PP, all HEVs expressed MAd-
CAM-1 and a few small HEVs expressed PNAd or VCAM-1.
Lymphocytes in BALT
We used two-color frozen section IF staining to determine
which lymphocyte subsets are present in BALT, and
whether certain subsets occupy specific microenviron-
ments within the tissue. Our stains revealed well demar-
cated B (CD19+) and T (CD3+) cell zones (Fig. 3A). The B
cells formed central aggregates that were surrounded by T
cells, most of which expressed CD4 (Figs. 3A and 3B).
CD45RO (memory marker) and CD45RA (naive marker)
were expressed on 86 ± 2% and 9 ± 2% of the CD4+ T cells
(n = 7 patients), respectively (Figs. 3C and 3D).
Next, we examined BALT T cells and B cells for the expres-
sion of L-selectin, which binds to PNAd; α4  integrin,
which is a subunit of α4β1 integrin (which binds mainly to
VCAM-1) and α4β7 integrin (which binds to MAdCAM-1);
and LFA-1, which binds to ICAM-1 and ICAM-2 [1]. Most
T cells (96 ± 5, n = 6 patients) expressed LFA-1 (Fig. 3E). A
minority of T cells expressed α4integrin (43 ± 12%) or L-
selectin (20 ± 19%) (Figs. 3F and 3G). In contrast, almost
all B cells expressed LFA-1, α4integrin and L-selectin. BALT
lymphocytes did not stain with the negative control mAbs
(Fig. 3H). Thus, BALT T cells differ from BALT B cells in
expression of adhesion molecules that are involved in
lymphocyte migration from the bloodstream into tissues.
Discussion
Migration of lymphocytes from blood vessels into tissues
is a complex process with multiple adhesion and activa-
tion steps [1,32]. Briefly, lymphocytes transiently adhere
to the endothelial surface of venules in the tissue (step 1),
are activated by chemokines (step 2), and adhere firmly to
the endothelia (step 3), before migrating through the ves-
sel wall into the tissue [1,32]. Thus, the adhesion mole-
cules that are expressed on the HEVs in a secondary
lymphoid tissue are important in determining which sub-
sets of lymphocytes migrate into the tissue. Here we eval-
uated BALT from lobectomy specimens of 17 human
adults with lung carcinoma for the expression of HEV and
lymphocyte adhesion molecules that might recruit lym-
phocytes from blood vessels into BALT. We found that
BALT HEVs expressed PNAd, ICAM-1 and ICAM-2, with or
without VCAM-1. MAdCAM-1 was not expressed on HEVs
in any of the BALT samples. The adhesion molecule pro-
file of HEVs in human BALT is similar to that of HEVs in
mouse BALT, differing only in the extent of VCAM-1
expression (66% of HEVs in human and 91% of HEVs in
mouse BALT) [9]. Thus, BALT in humans, as in mice [9],
has HEV adhesion molecules that are capable of recruiting
distinct subsets of lymphocytes from the bloodstream
into the tissue.
As in mice, the combination of adhesion molecules on
HEVs in human BALT differs from that on HEVs in other
secondary lymphoid tissues [9]. Specifically, VCAM-1,
which was expressed by endothelia of 66% of BALT HEVs
in our study, is not significantly expressed on HEV
endothelia in PP (Fig. 2D), adenoids and peripheral LNs
[31,33]. PNAd, which was strongly expressed on all HEVs
in BALT, is weakly expressed on HEVs in appendix and PP
(Fig. 2B) [34]. MAdCAM-1, which was not expressed on
BALT HEVs, is strongly expressed on appendix and PP
HEVs [30].
We found that 86% of BALT CD4+ T cells had a memory
phenotype (CD4+ CD45RO+). Since BALT does not have
afferent lymphatic vessels [6], these memory T cells mayRespiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
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have migrated through blood vessel HEVs into BALT and/
or may have arisen in situ from the maturation of naive T
cells. As in other secondary lymphoid tissues, BALT T cells
differ from B cells in adhesion molecule expression. L-
selectin, which binds to PNAd, was expressed on 20% of
T cells and almost all B cells in BALT. α4 integrin, which is
a subunit of α4β1 integrin that binds to VCAM-1, was
expressed on 43% of T cells and almost all B cells in BALT.
LFA-1, which binds to ICAM-1 and ICAM-2, was
expressed on almost all lymphocytes in BALT.
The Stamper-Woodruff in vitro binding assay can be used
to determine which adhesion molecules mediate the
binding of viable lymphocytes to HEVs on frozen sections
of tissues [12,35]. Due to the scarcity of frozen samples of
human BALT, we were unable to perform these assays.
However, our immunohistology studies on human and
mouse BALT and our functional studies on mouse BALT
[9] suggest that PNAd and VCAM-1 are involved in organ-
selective recruitment of specific subsets of lymphocytes to
human BALT. Specifically, L-selectin+ naive T cells could
be recruited from the bloodstream into human BALT by
binding to PNAd+ HEVs [36]. Since specialized cells, such
as M cells and/or dendritic cells, transport airway luminal
antigens into BALT, the naive T cells could meet antigen-
bearing dendritic cells in BALT, resulting in the generation
of lung-specific α4β1 integrin+ memory T cells. Following
release into the bloodstream, the α4β1 integrin+ memory T
cells could be recruited back to BALT by binding to
VCAM-1+ HEVs. Additionally, the α4β1 integrin+ memory
T cells could migrate into inflamed lungs by binding to
VCAM-1, which is highly expressed on vessels in human
inflamed lung [37-39]. Thus, in humans as in mice, the
VCAM-1/α4β1 integrin adhesion system may unify the
migration pathways of T cells into BALT and inflamed
lung.
The frequency of BALT in normal lungs of healthy adults
varies considerably between species. For example, BALT is
found in lungs of most normal adult rats, rabbits and
guinea pigs [5,6,10,12,13,40]. In contrast, the existence of
BALT in lungs of healthy adult humans is controversial. In
published reports, BALT was found in 0% to 74% of nor-
mal human lungs, as compared to 35% of lungs in our
study [14-16,18,20,41]. The marked differences in the fre-
quency of human BALT between studies may be due to
several factors, including the criteria used to determine if
the lung is "normal" and/or the person is "healthy", dif-
ferences in human subject populations, the source and
size of the specimen (i.e., bronchial biopsy, surgical
wedge resection, or surgical resection of a lobe or lung),
the number of tissue samples and sections examined, and
the histologic criteria used to identify BALT.
As with other lymphoid tissues, BALT can undergo
marked changes in size, cellular composition, and func-
tion during local immune responses. In animal models,
BALT can be induced and/or activated by infection or
immune stimulation of the lower respiratory tract [23,42-
45]. In humans, hyperplastic BALT can be seen in patents
with chronic pulmonary inflammatory disorders, such as
hypersensitivity pneumonitis, and in patients with
autoimmune diseases, including rheumatoid arthritis and
Sjogren's syndrome [15,46-50]. Exposure to irritants, such
as those in cigarette smoke, may influence the develop-
ment of BALT, as BALT was found in 82% of smoking and
14% of non-smoking human adults in one study [18]. In
our study, BALT was slightly more common in current
smokers (42%) than in non-smokers (29%).
It is clear from this study and previous studies that human
BALT shares many features with secondary lymphoid tis-
sues, including distinct T cell and B cell zones, follicular
dendritic cells, PNAd+ HEVs, and expression of lymphoid
chemokines CXCL13 and CCL21 (Fig. 2) [49]. Some
PNAd and VCAM-1 are expressed on HEVs in human BALT Figure 2 (see previous page)
PNAd and VCAM-1 are expressed on HEVs in human BALT. (A-H): Semi-serial frozen sections of BALT (A, C, E, G; 
arrowheads highlight the bronchial epithelium) and PP (B, D, F, H) were stained with mAbs against PNAd (A, B), VCAM-1 (C, 
D) and MAdCAM-1 (E, F), or with an isotype-matched negative control mAb (G, H). (A and B) PNAd is expressed on BALT 
HEVs (A; arrow highlights one HEV) and on a few vessels in PP (B; arrow). (C and D) VCAM-1 is expressed on BALT HEVs (C; 
arrow highlights one HEV) and on one vessel in PP (D; arrow). VCAM-1 is also expressed on non-endothelial cells in BALT and 
PP. (E and F) MAdCAM-1 is expressed on vessels in PP (F; arrow), but not in BALT (E). (G and H) Mouse IgG1 (for anti-
VCAM-1 and MAdCAM-1) and rat IgM (for anti-PNAd mAb; not shown) negative control mAbs did not stain HEVs in BALT 
(G) and PP (H). (A, C, E, G) The black granular material (highlighted by arrows in G) is carbon pigment in macrophages. (immu-
noperoxidase stains. original magnification 100×). (I-N): Semi-serial frozen sections of BALT were stained with mAbs against 
PNAd (green) and VCAM-1 (red) (I-K) or with anti-PNAd mAb (green) and negative control mAb (L-N) by two-color immun-
ofluorescence. Anti-PNAd mAb gave strong staining of BALT HEVs (I, L; arrows). The anti-VCAM-1 mAb stained HEVs (J; 
arrow) and non-endothelial cells in BALT. PNAd+VCAM-1+ (K; arrow) and PNAd+VCAM-1- (K; arrowhead) HEVs were found 
in BALT. The negative control mAb for VCAM-1 did not stain BALT (M, N). (two-color immunofluorescence stains. original 
magnification 200×).Respiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
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unique features of BALT in humans and animals, how-
ever, lead to the debate regarding whether BALT is a sec-
ondary lymphoid tissue controlled by a precise
developmental program or a tertiary lymphoid tissue con-
trolled by lymphoid neogenesis. BALT varies by species,
strain, age, and antigen stimulation: it is more common in
rabbits and rats than in mice [5,6,10,13,40]; autoim-
mune-prone nonobese diabetic mice and old mice have
more prominent BALT than nonautoimmune-prone and
young mice, respectively [9]; and antigen stimulation and
microbe infection can induce BALT formation in lungs of
mice [23,42,43,51]. Additionally, HEVs in mouse and
human BALT express VCAM-1 (Fig. 2) [9], which is fre-
quently seen on HEVs of tertiary lymphoid tissues but not
of LNs and PPs [52]. Thus, BALT is not identical to "con-
ventional" secondary lymphoid tissues such as LNs and
PPs.
A limitation of our study and of several other studies of
human bronchopulmonary immunology [35,53] is that
the tissues were obtained from carcinoma lobectomy
specimens. The factors, such as cigarette smoke, that led to
the development of the carcinoma could also lead to the
development of chronic inflammation, such as chronic
bronchitis. In addition, the carcinoma could initiate an
inflammatory response (for example, by obstructing a
bronchus, leading to post-obstructive pneumonia). We
made every effort to minimize these potential confound-
ing factors. Specifically, we excluded patients with 1)
known inflammatory pulmonary diseases; 2) macro-
scopic evidence of inflammation or infection in the lobec-
tomy specimen; or 3) histologic features of inflammation
or infection [29]. Moreover, we used strict histopathologic
criteria to identify "classic" BALT as described by Bienen-
stock and colleagues and in the pathology literature
[5,29].
Conclusion
In summary, we found that the HEVs in human BALT
express a unique set of adhesion molecules that are very
similar to those expressed in mouse BALT but markedly
different from those expressed in other human secondary
lymphoid tissues. The adhesion molecules on human
BALT HEVs may be important in recruiting specific sub-
sets of naive and memory/effector lymphocytes to BALT,
where they may be involved in the development of bron-
chopulmonary immune responses to inhaled antigens
and pathogens. Thus, BALT may be involved in the induc-
tion or/and modification of physiologic and pathologic
bronchopulmonary immune responses. Selective target-
ing of PNAd/L-selectin- and VCAM-1/α4β1 integrin-medi-
ated lymphocyte migration pathways might serve as a
novel strategy for treating inflammatory bronchopulmo-
nary diseases.
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BALT: bronchus-associated lymphoid tissue; HEVs: high
endothelial venules; Hr: hour; IF: immunofluorescence;
LNs: lymph nodes; mAb: monoclonal antibody; MAd-
CAM-1: mucosal addressin cell adhesion molecule-1;
Min: minutes; PBS: phosphate-buffered saline; PNAd:
peripheral node addressin; PPs: Peyer's patches; SD:
Standard derivation; VCAM-1: vascular cell adhesion mol-
ecule-1
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
NK and BHX contributed equally as co-first authors. SAM
and TM contributed equally as co-senior authors. NK,
BHX, SAM and TM designed the project, analyzed and
interpreted the data, and wrote the manuscript. HN per-
formed the lobectomies, collected and processed speci-
mens, obtained written informed consent from all
patients, and participated in data interpretation. NK, BHX,
KA and MK performed experiments. CT and TT partici-
pated in data analysis and interpretation. All authors read
and approved the final manuscript.
Acknowledgements
We thank Dr. Eugene C. Butcher at Stanford University and Dina Washing-
ton at Genentech Inc for providing mAbs for this study. This work was sup-
Lymphocytes in human BALT Figure 3 (see previous page)
Lymphocytes in human BALT. (A-D): Semi-serial frozen sections of BALT were stained with mAbs against CD19 and 
CD3 (A), CD4 and CD8 (B), CD4 and CD45RO (C), and CD4 and CD45RA (D). L is in the airway lumen of the bronchus. (A) 
B cell follicle (CD19+, red) surrounded by T cells (CD3+, green). (B) CD4+ cells (red) outnumber CD8+ cells (green). (C) 
Almost all BALT CD4+ cells have a memory phenotype (CD4+CD45RO+; yellow). (D) CD4+ cells with a naive phenotype 
(CD4+CD45RA+, yellow) are very rare in BALT. Most cells in the B cell follicle are CD4-CD45RA+ (green). (E-H): Semi-serial 
frozen sections of BALT from a different patient were stained with FITC-anti-CD3 mAb combined with a PE-conjugated mAb 
against an adhesion molecule or a negative control antigen. L is in the airway lumen of the bronchus. Most BALT T cells, as 
defined by expression of CD3, also expressed LFA-1 (E, yellow); a minority of BALT T cells expressed α4 integrin (F, yellow) or 
L-selectin (G, yellow). In contrast, most BALT B cells (CD3-) express LFA-1 (E, red), α4 integrin (F, red) and L-selectin (G, red). 
The PE-negative control mAb did not stain T or B cells in BALT (H). (two-color immunofluorescence stains. original magnifica-
tion 200×).Respiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
Page 10 of 11
(page number not for citation purposes)
ported by grants from the Japan Society for Science Promotion to Takami 
Matsuyama (C2-11670435) and Baohui Xu (C2-12671664); a Digestive Dis-
ease Center grant (DK56339) from the NIH; and grants from the NIH 
(RO1 DE014385) and Sjogren's Syndrome Foundation to Sara Michie.
References
1. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis.
Science 1996, 272:60-66.
2. Dutton RW, Bradley LM, Swain SL: T cell memory.  Annu Rev Immu-
nol 1998, 16:201-223.
3. Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt
RL, Itano A, Pape KA: In vivo activation of antigen-specific CD4
T cells.  Annu Rev Immunol 2001, 19:23-45.
4. Sprent J, Surh CD: T cell memory.  Annu Rev Immunol 2002,
20:551-579.
5. Bienenstock J, Johnston N: A morphologic study of rabbit bron-
chial lymphoid aggregates and lymphoepithelium.  Lab Invest
1976, 35:343-348.
6. Sminia T, Brugge-Gamelkoorn GJ van der, Jeurissen SH: Structure
and function of bronchus-associated lymphoid tissue
(BALT).  Crit Rev Immunol 1989, 9:119-150.
7. Bienenstock J, McDermott MR: Bronchus- and nasal-associated
lymphoid tissues.  Immunol Rev 2005, 206:22-31.
8. Bienenstock J, Befus D: Gut- and bronchus-associated lymphoid
tissue.  Am J Anat 1984, 170:437-445.
9. Xu B, Wagner N, Pham LN, Magno V, Shan Z, Butcher EC, Michie SA:
Lymphocyte homing to bronchus-associated lymphoid tissue
(BALT) is mediated by L-selectin/PNAd, alpha4beta1
integrin/VCAM-1, and LFA-1 adhesion pathways.  J Exp Med
2003, 197:1255-1267.
10. Plesch BE, Gamelkoorn GJ, Ende M van de: Development of bron-
chus associated lymphoid tissue (BALT) in the rat, with spe-
cial reference to T- and B-cells.  Dev Comp Immunol 1983,
7:179-188.
11. Sato A: [Basic and clinical aspects of bronchus-associated
lymphoid tissue].  Nihon Kokyuki Gakkai Zasshi 2000, 38:3-11.
12. Brugge-Gamelkoorn GJ van der, Kraal G: The specificity of the
high endothelial venule in bronchus-associated lymphoid tis-
sue (BALT).  J Immunol 1985, 134:3746-3750.
13. Simecka JW, Davis JK, Cassell GH: Distribution of Ia antigens and
T lymphocyte subpopulations in rat lungs.  Immunology 1986,
57:93-98.
14. Hiller AS, Tschernig T, Kleemann WJ, Pabst R: Bronchus-associ-
ated lymphoid tissue (BALT) and larynx-associated lym-
phoid tissue (LALT) are found at different frequencies in
children, adolescents and adults.  Scand J Immunol 1998,
47:159-162.
15. Tschernig T, Pabst R: Bronchus-associated lymphoid tissue
(BALT) is not present in the normal adult lung but in differ-
ent diseases.  Pathobiology 2000, 68:1-8.
16. Tschernig T, Kleemann WJ, Pabst R: Bronchus-associated lym-
phoid tissue (BALT) in the lungs of children who had died
from sudden infant death syndrome and other causes.  Thorax
1995, 50:658-660.
17. Gould SJ, Isaacson PG: Bronchus-associated lymphoid tissue
(BALT) in human fetal and infant lung.  J Pathol 1993,
169:229-234.
18. Richmond I, Pritchard GE, Ashcroft T, Avery A, Corris PA, Walters
EH: Bronchus associated lymphoid tissue (BALT) in human
lung: its distribution in smokers and non-smokers.  Thorax
1993, 48:1130-1134.
19. Sue-Chu M, Karjalainen EM, Altraja A, Laitinen A, Laitinen LA, Naess
AB, Larsson L, Bjermer L: Lymphoid aggregates in endobron-
chial biopsies from young elite cross-country skiers.  Am J
Respir Crit Care Med 1998, 158:597-601.
20. Elliot JG, Jensen CM, Mutavdzic S, Lamb JP, Carroll NG, James AL:
Aggregations of lymphoid cells in the airways of nonsmok-
ers, smokers, and subjects with asthma.  Am J Respir Crit Care
Med 2004, 169(6):712-718.
21. Luhrmann A, Tschernig T, Pabst R: Stimulation of bronchus-asso-
ciated lymphoid tissue in rats by repeated inhalation of aer-
osolized lipopeptide MALP-2.  Pathobiology 2002, 70:266-269.
22. Lugton I: Mucosa-associated lymphoid tissues as sites for
uptake, carriage and excretion of tubercle bacilli and other
pathogenic mycobacteria.  Immunol Cell Biol 1999, 77:364-372.
23. Toyoshima M, Chida K, Sato A: Antigen uptake and subsequent
cell kinetics in bronchus-associated lymphoid tissue.  Respirol-
ogy 2000, 5:141-145.
24. Morin MJ, Warner A, Fields BN: A pathway for entry of retrovi-
ruses into the host through M cells of the respiratory tract.  J
Exp Med 1994, 180:1523-1527.
25. Teitelbaum R, Schubert W, Gunther L, Kress Y, Macaluso F, Pollard
JW, McMurray DN, Bloom BR: The M cell as a portal of entry to
the lung for the bacterial pathogen Mycobacterium tubercu-
losis.  Immunity 1999, 10:641-650.
26. Gebert A, Steinmetz I, Fassbender S, Wendlandt KH: Antigen
transport into Peyer's patches: increased uptake by constant
numbers of M cells.  Am J Pathol 2004, 164:65-72.
27. Picker LJ, Butcher EC: Physiological and molecular mechanisms
of lymphocyte homing.  Annu Rev Immunol 1992, 10:561-591.
28. Cesta MF: Normal structure, function, and histology of
mucosa-associated lymphoid tissue.  Toxicol Pathol 2006,
34:599-608.
29. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM,
Glanville A, Gould FK, Magro C, Marboe CC, et al.: Revision of the
1996 working formulation for the standardization of nomen-
clature in the diagnosis of lung rejection.  J Heart Lung Transplant
2007, 26:1229-1242.
30. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J,
McEvoy LM, Butcher EC, Kassam N, Mackay CR, et al.: Human
mucosal addressin cell adhesion molecule-1 is preferentially
expressed in intestinal tract and associated lymphoid tissue.
Am J Pathol 1997, 151:97-110.
31. Perry ME, Kirkpatrick WN, Happerfield LC, Gleeson MJ: Expression
of adhesion molecules on the microvasculature of the pha-
ryngeal tonsil (adenoid).  Acta Otolaryngol Suppl 1996, 523:47-51.
32. Cyster JG: Chemokines and cell migration in secondary lym-
phoid organs.  Science 1999, 286(5447):2098-2102.
33. Tanaka H, Saito S, Sasaki H, Arai H, Oki T, Shioya N: Morphological
aspects of LFA-1/ICAM-1 and VLA4/VCAM-1 adhesion path-
ways in human lymph nodes.  Pathol Int 1994, 44:268-279.
34. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ: The human
peripheral lymph node vascular addressin. An inducible
endothelial antigen involved in lymphocyte homing.  Am J
Pathol 1993, 143:1688-1698.
35. Ainslie MP, McNulty CA, Huynh T, Symon FA, Wardlaw AJ: Charac-
terisation of adhesion receptors mediating lymphocyte
adhesion to bronchial endothelium provides evidence for a
distinct lung homing pathway.  Thorax 2002, 57:1054-1059.
36. Berg EL, Robinson MK, Warnock RA, Butcher EC: The human
peripheral lymph node vascular addressin is a ligand for
LECAM-1, the peripheral lymph node homing receptor.  J Cell
Biol 1991, 114:343-349.
37. van Dinther-Janssen AC, van Maarsseveen TC, Eckert H, Newman W,
Meijer CJ: Identical expression of ELAM-1, VCAM-1, and
ICAM-1 in sarcoidosis and usual interstitial pneumonitis.  J
Pathol 1993, 170:157-164.
38. Ohkawara Y, Yamauchi K, Maruyama N, Hoshi H, Ohno I, Honma M,
Tanno Y, Tamura G, Shirato K, Ohtani H: In situ expression of the
cell adhesion molecules in bronchial tissues from asthmatics
with air flow limitation: in vivo evidence of VCAM-1/VLA-4
interaction in selective eosinophil infiltration.  Am J Respir Cell
Mol Biol 1995, 12:4-12.
39. Brodie SJ, de la Rosa C, Howe JG, Crouch J, Travis WD, Diem K:
Pediatric AIDS-associated lymphocytic interstitial pneumo-
nia and pulmonary arterio-occlusive disease: role of VCAM-
1/VLA-4 adhesion pathway and human herpesviruses.  Am J
Pathol 1999, 154:1453-1464.
40. Sato A: Bronchus-associated lymphoid tissue (BALT).  Nihon
Kokyuki Gakkai Zasshi 2003:235-236.
41. Pabst R, Gehrke I: Is the bronchus-associated lymphoid tissue
(BALT) an integral structure of the lung in normal mam-
mals, including humans?  Am J Respir Cell Mol Biol 1990, 3:131-135.
42. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB: Viral-induced T
helper type 1 responses enhance allergic disease by effects
on lung dendritic cells.  Nat Immunol 2004, 5:337-343.
43. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F,
Goodrich S, Woodland DL, Lund FE, Randall TD: Role of inducible
bronchus associated lymphoid tissue (iBALT) in respiratory
immunity.  Nat Med 2004, 10:927-934.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2009, 10:97 http://respiratory-research.com/content/10/1/97
Page 11 of 11
(page number not for citation purposes)
44. Iwata M, Sato A: Morphological and immunohistochemical
studies of the lungs and bronchus-associated lymphoid tissue
in a rat model of chronic pulmonary infection with Pseu-
domonas aeruginosa.  Infect Immun 1991, 59:1514-1520.
45. Pabst R, Durak D, Roos A, Luhrmann A, Tschernig T: TLR2/6 stim-
ulation of the rat lung: effects on lymphocyte subsets, natu-
ral killer cells and dendritic cells in different parts of the air-
conducting compartments and at different ages.  Immunology
2009, 126:132-139.
46. Sato A, Chida K, Iwata M, Hayakawa H: Study of bronchus-associ-
ated lymphoid tissue in patients with diffuse panbronchioli-
tis.  Am Rev Respir Dis 1992, 146:473-478.
47. Sato A, Hayakawa H, Uchiyama H, Chida K: Cellular distribution
of bronchus-associated lymphoid tissue in rheumatoid
arthritis.  Am J Respir Crit Care Med 1996, 154:1903-1907.
48. Suda T, Chida K, Hayakawa H, Imokawa S, Iwata M, Nakamura H, Sato
A: Development of bronchus-associated lymphoid tissue in
chronic hypersensitivity pneumonitis.  Chest 1999,
115:357-363.
49. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Ran-
dall TD: Inducible bronchus-associated lymphoid tissue
(iBALT) in patients with pulmonary complications of rheu-
matoid arthritis.  J Clin Invest 2006, 116:3183-3194.
50. Leslie KO, Trahan S, Gruden J: Pulmonary pathology of the rheu-
matic diseases.  Semin Respir Crit Care Med 2007, 28:369-378.
51. Chvatchko Y, Kosco-Vilbois MH, Herren S, Lefort J, Bonnefoy JY:
Germinal center formation and local immunoglobulin E
(IgE) production in the lung after an airway antigenic chal-
lenge.  J Exp Med 1996, 184:2353-2360.
52. Mikulowska-Mennis A, Xu B, Berberian JM, Michie SA: Lymphocyte
migration to inflamed lacrimal glands is mediated by vascu-
lar cell adhesion molecule-1/alpha(4)beta(1) integrin,
peripheral node addressin/l-selectin, and lymphocyte func-
tion-associated antigen-1 adhesion pathways.  Am J Pathol 2001,
159:671-681.
53. Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M,
Andrew DP, Wu L, Butcher EC, Wardlaw AJ: Expression of chem-
okine receptors by lung T cells from normal and asthmatic
subjects.  J Immunol 2001, 166:2842-2848.